Chronic blood transfusion in a long-survivor sickle cell anaemia patient

Authors

  • J.A. Olaniyi
  • C.U. Akunwata
  • Y.A. Aken'Ova

Keywords:

Sickle Cell Anaemia, chronic blood transfusion, iron overload, organ failure

Abstract

Background: Multiple blood transfusions, with consequent iron overload, are inevitable in Sickle Cell Anaemia (SCA) patients who suffer from chronic haemolytic process that is frequently complicated by hyper-haemolytic crisis.

Objective: This paper reports the long term effects of blood transfusion in a long surviving SCA patient and to emphasize the need for exchange blood transfusions, regular iron studies and the need for chelation therapy in order to avoid organ failures.

Materials & Method: The hospital record of the patient was reviewed.

Results: This case typifies one of the extremes of transfusion requirement in a sickle cell anaemia patient. She survived multiple crises and complications of the disease up to the age of sixty one years, but in the course of the disease, she developed chronic kidney disease that warranted multiple episodic and chronic blood transfusions. The associated hypertension and subsequent heart failure led to her sudden death. Altogether, she received 40 units of blood, amounting to about 8,800 mg of exogenous iron.  Iron overload was therefore a possible contributory factor to organ failures and death. However, patient's family refused post mortem examination which could have been helpful to determine iron load in the liver, heart and the bone marrow retrospectively.

Conclusion: In view of the complications of multiple blood transfusions with consequent iron overload in SCA patients, the use of artificial blood, regular use of hydroxyurea, iron chelation therapy when indicated will go a long way in improving survival in SCA patients.

References

Adekile AD. Heamoglobinopathies. In Azubuike JC, Nkanginieme KED, eds. Paediatrics and Child Health in Tropical Region . African Educational Services, 1999: 194-213.

Akinyanju OO. Profile of sickle cell disease in Nigeria. Ann. NY Acad. Sci.,

, 565: 126-136

Raghupathy R, Manwani D and Little J.A. Iron Overload in Sickle Cell Disease. Advances in Haematology.

0 1 0 ; http://dx.doi.org/10.1155/2010/272940.

PMCID:PMC2872757.

Kenneth I.A., Eugene P.O. Renal abnormalities in sickle cell disease 2000; 63(4):204-211.

Davies S., Brozovic M. The presentation, management and

prophylaxis of sickle cell disease. Blood Reviews 1989; 3: 29-44.

Keidan A., Marwah S., Vaughan G.,

Franklin I., Staut J. Painful sickle cell crises precipitated by stopping prophylactic exchange transfusion. J Clin Pathol 1987; 40: 505-507.

Rosse W, Gallagher D, Kinney T, Castro O, Dosik H, Moohr J, et al. Transfusion and allo-immunization in sickle cell disease. The cooperative study of sickle cell disease. Blood 1990; 76: 1431-7.

Olopoenia L, Fredrick W, Greaves W, Adams R, Addo F, Castro O.

Pneumococcal sepsis and meningitis in adults with sickle cell disease. Southern Medical Journal 1990; 83: 102-104.

Overturf G, Powars D, Baraff L.

Bacterial meningitis and septicaemia in sickle cell disease. American Journals of Diseases of Childhood 1977; 131:784-7.

Landesman S, Rao S, Ahonkhai V. Infection in children with sickle cell a n a e m i a . S p e c i a l r e f e r e n c e topneumococcal and salmonella infections. American Journal of Paediatric Haematologic and Oncology 1982; 4: 407-18.

Fernbach D,Burdine Jr. J. Sepsis and functional asplenia. New England Journal of Medicine 1970; 282: 691.

Humbert J, Winsor E, Githens J, Schmitz J. Neutrophils dysfunction in sickle cell disease. Biomed Pharmacother 1990; 44: 153-8.

Downloads

Published

2023-09-13

How to Cite

Olaniyi, J., Akunwata, C., & Aken’Ova , Y. (2023). Chronic blood transfusion in a long-survivor sickle cell anaemia patient. Research Journal of Health Sciences, 1(1), 26–30. Retrieved from https://rjhs.org/index.php/home/article/view/46